Journal article

Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection

S Venkatesan, PR Myles, KJ Bolton, SG Muthuri, T Al Khuwaitir, AP Anovadiya, E Azziz-Baumgartner, T Bajjou, M Bassetti, B Beovic, B Bertisch, I Bonmarin, R Booy, VH Borja-Aburto, H Burgmann, B Cao, J Carratala, T Chinbayar, C Cilloniz, JT Denholm Show all

Journal of Infectious Diseases | OXFORD UNIV PRESS INC | Published : 2020

Abstract

BACKGROUND: The effect of neuraminidase inhibitor (NAI) treatment on length of stay (LoS) in patients hospitalized with influenza is unclear. METHODS: We conducted a one-stage individual participant data (IPD) meta-analysis exploring the association between NAI treatment and LoS in patients hospitalized with 2009 influenza A(H1N1) virus (A[H1N1]pdm09) infection. Using mixed-effects negative binomial regression and adjusting for the propensity to receive NAI, antibiotic, and corticosteroid treatment, we calculated incidence rate ratios (IRRs) and 95% confidence intervals (CIs). Patients with a LoS of <1 day and those who died while hospitalized were excluded. RESULTS: We analyzed data on 18 3..

View full abstract

University of Melbourne Researchers